Global /Japan /Healthcare /Drug Manufacturers - General /4886
chevron_leftBack
ASKA Pharmaceutical Holdings Co.,Ltd. logo

ASKA Pharmaceutical Holdings Co.,Ltd.

4886
TSE: 4886 Delayed
2,916JPY -2.3%
18.21 USD
As of 6 June 2026, ASKA Pharmaceutical Holdings Co.,Ltd. has a market cap of $529.68M USD, ranking #14740 globally and #1084 in Japan. It ranks #1311 in the Healthcare sector, and #484 in the Drug Manufacturers - General industry.
Global Rank
14740
Country Rank
1084
Sector Rank
1311
Industry Rank
484
Key Stats
Market Cap
$529.68MUSD
84.76B JPY
Enterprise Value
$611.25MUSD
97.9B JPY
Revenue (TTM)
$429.3MUSD
68.7B JPY
EBITDA (TTM)
$41.74MUSD
6.68B JPY
Net Income (TTM)
$30.66MUSD
4.91B JPY
PE Ratio
17.3
Forward PE
15.4
PS Ratio
1.2
PB Ratio
1.1
EV/EBITDA
15.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sohta Yamaguchi open_in_new
Employees
1,632
Founded
1920
Website
aska-pharma-hd.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.3% 3.2% 26% 39% 36% 30%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
4886
あすか製薬ホールディングス株式会社
ISIN: JP3119660003
Shares Out.:
28.396M1 Shares Float: 17.99M2
TV:
SA:
YF:
GF:
BA:
MS:
2,916 JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About ASKA Pharmaceutical Holdings Co.,Ltd.

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Similar Companies

Industry: Drug Manufacturers - General (Japan)
Name
Market Cap diff.
PE
$81.66B
13.07T JPY
15K%
28.9
$52.21B
8.36T JPY
10K%
75.1
$36.84B
5.9T JPY
7K%
15.7
$30.37B
4.86T JPY
6K%
16.2
$25.82B
4.13T JPY
5K%
14.2
$16.91B
2.71T JPY
3K%
13.9
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
144K%
38.1
JNJ
$547.28B
103K%
26.4
ABBV
$360.63B
68K%
97.4
$324.68B
256.25B CHF
61K%
19.9
AZN
$289.43B
215.59B GBP
55K%
27.6
NOVN
$277.35B
218.9B CHF
52K%
20.5
chevron_leftBack